Insider digest · PFE
Pfizer insider filings, Oct 1, 2026
Pfizer insiders filed 1 routine Form 4 report on Oct 1, 2026: awards. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.
What the codes mean: how to read a Form 4 · stock-based compensation.
Stock awards and grants
Shares or units the company granted as pay. No shares were bought or sold in the market. Total for the day: 21 shares or units, worth about $599 at the prices reported.
| Person | Code | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Albert Bourla · Chairman & CEO and a director | A | Phantom Stock Units SSP | 21 | $28.52 | $599 | 783,888 |
The filings
- Pfizer Chairman & CEO Albert Bourla reports an award of 21 phantom stock units SSP · SEC filing index
Pfizer company file → · All Pfizer filings notes
Disclosures
- Editor holdings in PFE
- The editor holds no position in Pfizer (PFE). As of Nov 11, 2026.
- Compensation
- Nobody paid for this page. No affiliate links.
A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold PFE.